User profiles for Valeria De Giorgi

Valeria De Giorgi

National Institutes of Health
Verified email at mail.nih.gov
Cited by 1366

[HTML][HTML] An immunologic portrait of cancer

ML Ascierto, VD Giorgi, Q Liu, D Bedognetti… - Journal of translational …, 2011 - Springer
The advent of high-throughput technology challenges the traditional histopathological
classification of cancer, and proposes new taxonomies derived from global transcriptional patterns…

[HTML][HTML] Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis

…, L Uccellini, ML Ascierto, G Zoppoli, V De Giorgi… - Journal of translational …, 2011 - Springer
In humans, the role and relationship between molecular pathways that lead to tissue destruction
during acute allograft rejection are not fully understood. Based on studies conducted in …

[HTML][HTML] Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions

M Myint, F Oppedisano, V De Giorgi, BM Kim… - Journal of Translational …, 2023 - Springer
Liver steatosis, inflammation, and variable degrees of fibrosis are the pathological
manifestations of nonalcoholic steatohepatitis (NASH), an aggressive presentation of the most …

[HTML][HTML] CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2

…, S Tomei, ME Dudley, ML Ascierto, V De Giorgi… - British journal of …, 2013 - nature.com
Background: Adoptive therapy with tumour-infiltrating lymphocytes (TILs) induces durable
complete responses (CR) in∼ 20% of patients with metastatic melanoma. The recruitment of T …

Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma

…, A Worschech, V De Giorgi… - Proceedings of the …, 2012 - National Acad Sciences
Because oncogene MET and EGF receptor (EGFR) inhibitors are in clinical development
against several types of cancer, including glioblastoma, it is important to identify predictive …

Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection

V De Giorgi, KA West, AN Henning… - The Journal of …, 2021 - academic.oup.com
Background Characterizing the kinetics of the antibody response to severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) is of critical importance to developing strategies …

Pooled saliva specimens for SARS-CoV-2 testing

B Barat, S Das, V De Giorgi… - Journal of clinical …, 2021 - Am Soc Microbiol
We evaluated saliva (SAL) specimens for SARS-CoV-2 reverse transcriptase PCR (RT-PCR)
testing by comparison of 459 prospectively paired nasopharyngeal (NP) or midturbinate (…

Circulating let‐7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C

K Matsuura, V De Giorgi, C Schechterly, RY Wang… - Hepatology, 2016 - journals.lww.com
The goal of this study was to determine whether an association exists between circulating
microRNA (miRNA) levels and disease progression in chronic hepatitis C (CHC), whether …

[HTML][HTML] mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants

…, D Esposito, Z Kang, J Lu, AT Remaley, V De Giorgi… - Scientific Reports, 2022 - nature.com
Several variants of SARS-CoV-2 have emerged. Those with mutations in the angiotensin-converting
enzyme (ACE2) receptor binding domain (RBD) are associated with increased …

Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8+ T cells for adoptive immunotherapy

…, W Hobo, Y Ji, H Fredrix, V De Giorgi… - …, 2018 - Taylor & Francis
Adoptive T cell therapy has shown clinical potential for patients with cancer, though effective
treatment is dependent on longevity and potency of the exploited tumor-reactive T cells. …